Development of an Evidence-Based Risk Assessment Framework

Abstract

Assessment of potential human health risks associated with environmental and other agents requires careful evaluation of all available and relevant evidence for the agent of interest, including both data-rich and data-poor agents. With the advent of new approach methodologies in toxicological risk assessment, guidance on integrating evidence from multiple evidence streams is needed to ensure that all available data is given due consideration in both qualitative and quantitative risk assessment. The present report summarizes the discussions among academic, government, and private sector participants from North America and Europe in an international workshop convened to explore the development of an evidence-based risk assessment framework, taking into account all available evidence in an appropriate manner in order to arrive at the best possible characterization of potential human health risks, and associated uncertainty. Although consensus among workshop participants was not a specific goal, there was general agreement on the key considerations involved in evidence-based risk assessment incorporating 21 st century science into human health risk assessment. These considerations have been embodied into an overarching prototype framework for evidence integration that will be explored in more depth in a follow-up meeting.

A call for a Human Exposome Project

“…High-throughput data generation for relevant big data that answers important safety questions, e.g., realistic exposures, potencies, mixtures, interindividual differences. Andersen et al, 2019;Jacobs et al, 2019;de Souza Santos et al, 2018;Aschner et al, 2017;Gordon et al, 2015;Patlewicz et al, 2014;Juberg et al, 2014;Smirnova et al, 2014;Hartung and Corsini, 2013;Parks Saldutti et al, 2013;Rossini and Hartung, 2012;Basketter et al, 2012;Kuegler et al, 2010;Hartung and Hoffmann, 2009;Leist et al, 2008a; Krewski et al, 2022;Maertens et al, 2022;Farhat et al, 2022;Caloni et al, 2022;Hoffmann et al, 2022a,b;Hartung, 2017cHartung, , 2021bHoffmann et al, 2017;Linkov et al, 2015;Hartung, 2009bMetabolomics Lippa et al, 2022Evans et al, 2020;Beger et al, 2019; ALTEX 35, 306-352. doi:10.14573/altex.1712081 Basketter, D. A., Clewell, H., Kimber, I. et al (2012). A roadmap for the development of alternative (non-animal) methods for systemic toxicity testing.…”